Company / Working Capital
ENDONOVO THERAPEUTICS, INC. Working Capital History
FY2011-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$33.4M
FY2022
5-year range
-$33.4M / -$15.1M
FY2018-FY2022
Trend
-89.5%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 9 years, ranging from -$33M in FY2022 to $69,797 in FY2011.
Based on SEC 10-K filings.
-$33M in FY2022.
Declined from -$17M to -$33M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, working capital decreased 89.5% year-over-year.
- Peak working capital was recorded in FY2011.
Company context
Key Data Points
- Altman Z-Score -76.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$33.4M | -89.5% |
| FY2021 | -$17.6M | -4.9% |
| FY2020 | -$16.8M | +28.8% |
| FY2019 | -$23.6M | -56.1% |
| FY2018 | -$15.1M | -79.3% |
| FY2016 | -$8.4M | +7.6% |
| FY2015 | -$9.1M | -100.1% |
| FY2014 | -$4.6M | -6621.7% |
| FY2011 | $69.8K | - |
As of FY2022 · SEC 10-K · Updated Jun 29, 2026